Skip to main content
Log in

Benzyl-N-acetyl-α-d-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation

  • Papers
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

We have analysed the mucins synthesized by the HT-29 MTX cell subpopulation, derived from the HT-29 human colon carcinoma cells through a selective pressure with methotrexate (Lesuffleuret al., 1990,Cancer Res 50: 6334–43), in the presence of benzyl-N-acetyl-α-galactosaminide (GalNAcα-O-benzyl), which is a potential competitive inhibitor of the β1,3-galactosyltransferase that synthesizes the T-antigen. The main observation was a 13-fold decrease in the sialic acid content of mucins after 24 h of exposure to 5mm GalNAcα-O-benzyl. This effect was accompanied by an increased reactivity of these mucins to peanut lectin, testifying to the higher amount of T-antigen. The second observation was a decrease in the secretion of the mucins by GalNAcα-O-benzyl treated cells. The decrease in mucin sialyation was achieved through thein situ β-galactosylation of GalNAcα-O-benzyl into Galβ1–3GalNAcα-O-benzyl, which acts as a competitive substrate of Galβ1–3GalNAc α2,3-sialyltransferase, as shown by the intracellular accumulation of NeuAcα2–3Galβ1–3GalNAcα-O-benzyl in treated cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BSM:

bovine submaxillary mucin

MTX:

methotrexate

PBS:

sodium phosphate 10mm, NaCl 0.15m, pH 7.4 buffer

pNp:

p-nitrophenol

TBS:

Tris/HCl 10mm, NaCl 0.15m, pH 7.4 buffer

References

  1. Bhavanandan VP (1991)Glycobiology 1: 493–503.

    Google Scholar 

  2. Rose MC (1992)Am Physiol Soc 263: L413–17.

    Google Scholar 

  3. Kurosaka A, Nakajima H, Funakoshi I, Matsuyama M, Nagayo T, Yamashina I (1983)J Biol Chem 258: 11594–98.

    Google Scholar 

  4. Kim YS (1992)J Cell Biochem Suppl 16G: 91–96.

    Google Scholar 

  5. Varki A (1993)Glycobiology 3: 97–130.

    Google Scholar 

  6. Pinto M, Appay MD, Simon-Assmann P, Chevalier G, Drocopoli N, Fogh J, Zweibaum A (1982)Biol Cell 44: 193–96.

    Google Scholar 

  7. Augeron C, Laboisse CL (1984)Cancer Res 44: 3961–69.

    Google Scholar 

  8. Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A (1990)Cancer Res 50: 6334–43.

    Google Scholar 

  9. Maoret JJ, Font J, Augeron C, Codogno P, Baury C, Aubery M, Laboisse CL (1989)Biochem J 258: 793–99.

    Google Scholar 

  10. Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B, Zweibaum A (1991)Int J Cancer 49: 721–30.

    Google Scholar 

  11. Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A (1993)J Cell Sci 106: 771–83.

    Google Scholar 

  12. Kuan SF, Byrd JC, Basbaum C, Kim YS (1989)J Biol Chem 264: 19271–77.

    Google Scholar 

  13. Huang J, Byrd JC, Yoon WH, Kim YS (1992)Oncol Res 4: 507–15.

    Google Scholar 

  14. DiIulio NA, Bhavanandan VP (1995)Glycobiology 5: 195–99.

    Google Scholar 

  15. Duk M, Steuden I, Dus D, Radzikowski C, Lisowska E (1992)Glycoconjugate J 9: 148–53.

    Google Scholar 

  16. Steuden I, Duk M, Czerwinski M, Radzikowski C, Lisowska E (1985)Glycoconjugate J 2: 303–14.

    Google Scholar 

  17. Huet G, Kim I, De Bolos C, Lo-Guidice JM, Moreau O, Hemon B, Richet C, Delannoy P, Real FX, Degand P (1995)J Cell Sci 108: 1275–85.

    Google Scholar 

  18. Houdret N, Perini JM, Galabert C, Scharfman A, Humbert P, Lamblin G, Roussel P (1986)Biochim Biophys Acta 880: 54–61.

    Google Scholar 

  19. De Jong JGN, Wevers RA, Sambeek RLV (1992)Clin Chem 38: 803–7.

    Google Scholar 

  20. Lamblin G, Boersma A, Klein A, Roussel P, Van Halbeek H, Vliegenthart JFG (1984)J Biol Chem 259: 9051–58.

    Google Scholar 

  21. Lo-Guidice JM, Wieruszeski JM, Lemoine J, Verbert A, Roussel P, Lamblin G (1994)J Biol Chem 269: 18794–813.

    Google Scholar 

  22. Laemmli UK (1970)Nature 227: 680–81.

    Google Scholar 

  23. Vaessen RTMJ, Kreike J, Groot GSP (1981)FEBS Lett 124: 193–96.

    Google Scholar 

  24. Peterson GL (1977)Anal Biochem 83: 346–56.

    Google Scholar 

  25. Dall'Olio F, Malagolini N, Serafini-Cessi F (1992)Biochem Biophys Res Commun 184: 1405–10.

    Google Scholar 

  26. Delannoy P, Pelczar H, Vandamme V, Verbert A (1993)Glycoconjugate J 10: 91–98.

    Google Scholar 

  27. Vandamme V, Cazlaris H, Le Marer N, Laudet V, Lagrou C, Verbert A, Delannoy P (1992)Biochimie 74: 89–100.

    Google Scholar 

  28. Schachter H, Brockhausen I (1989) InMucus and Related Topics (Chantler E, Ratcliffe NA, eds) pp. 1–26, Cambridge: Society for Experimental Biology.

    Google Scholar 

  29. Dall'Olio F, Malagolini N, Guerrini S, Serafini-Cessi F (1993)Biochem Biophys Res Commun 196: 714–20.

    Google Scholar 

  30. Capon C, Laboisse CL, Wieruszeski JM, Maoret JJ, Augeron C, Fournet B (1992)J Biol Chem 267: 19248–57.

    Google Scholar 

  31. Joziasse DH, Bergh MLE, ter Hart HGJ, Koppen PL, Hooghwinkel GJM, Van den Eijnden DH (1985)J Biol Chem 260: 4941–51.

    Google Scholar 

  32. Kuhns W, Rutz V, Paulsen H, Matta KL, Baker MA, Barner M, Granovsky M, Brockhausen I (1993)Glycoconjugate J 10: 381–94.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Enzymes: CMP-NeuAc: Galβ1–3/4GlcNAc α2,3-sialyltransferase, ST3(N), EC 2.4.99.6; CMP-NeuAc: Galβ1–4GlcNAc α2,6-sialyltransferase, ST6(N), EC 2.4.99.1; CMP-NeuAc: Galβ1–3GalNAc α2,3-sialyltransferase, ST3(O), EC 2.4.99.4; CMP-NeuAc: R-GalNAcα1-O-Ser α2,6-sialyltransferase, ST6(O)-I, EC 2.4.99.3; CMP-NeuAc: NeuAcα2–3Galβ1–3GalNAc α2,6-sialyltransferase, ST6(O)-II, EC 2.4.99.7; UDP-GlcNAc: Galβ1–3GalNAc-R·(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, EC 2.4.1.102; UDP-GlcNAc: GalNAcα-R β1,3-N-acetylglucosaminyltransferase, EC 2.4.1.147; UDP-Gal: GalNAc-R β1,3-galactosyltransferase, EC 2.4.1.122.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Delannoy, P., Kim, I., Emery, N. et al. Benzyl-N-acetyl-α-d-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconjugate J 13, 717–726 (1996). https://doi.org/10.1007/BF00702335

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00702335

Keywords

Navigation